ARCHIVES

Unclear Whether Clinical Trials Benefit Patients, Review Finds

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

Avastin Improves PFS Compared To Chemo Alone

January 29, 2010

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980